PL365739A1 - Substituted imidazopyridines - Google Patents

Substituted imidazopyridines

Info

Publication number
PL365739A1
PL365739A1 PL01365739A PL36573901A PL365739A1 PL 365739 A1 PL365739 A1 PL 365739A1 PL 01365739 A PL01365739 A PL 01365739A PL 36573901 A PL36573901 A PL 36573901A PL 365739 A1 PL365739 A1 PL 365739A1
Authority
PL
Poland
Prior art keywords
substituted imidazopyridines
imidazopyridines
substituted
Prior art date
Application number
PL01365739A
Other languages
Polish (pl)
Inventor
Kyle J. Lindstrom
Original Assignee
3M Innovative Properties Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3M Innovative Properties Company filed Critical 3M Innovative Properties Company
Publication of PL365739A1 publication Critical patent/PL365739A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
PL01365739A 2000-12-08 2001-12-06 Substituted imidazopyridines PL365739A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25422800P 2000-12-08 2000-12-08
PCT/US2001/046915 WO2002046194A2 (en) 2000-12-08 2001-12-06 Substituted imidazopyridines

Publications (1)

Publication Number Publication Date
PL365739A1 true PL365739A1 (en) 2005-01-10

Family

ID=22963437

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01365739A PL365739A1 (en) 2000-12-08 2001-12-06 Substituted imidazopyridines

Country Status (23)

Country Link
EP (1) EP1343783A2 (en)
JP (1) JP2004525868A (en)
KR (1) KR20030070048A (en)
CN (1) CN1249062C (en)
AR (1) AR035670A1 (en)
AU (2) AU2002239547B2 (en)
BR (1) BR0116034A (en)
CA (1) CA2431040A1 (en)
CZ (1) CZ20031593A3 (en)
EE (1) EE200300273A (en)
HR (1) HRP20030465A2 (en)
HU (1) HUP0600592A2 (en)
IL (1) IL155885A0 (en)
MX (1) MXPA03005013A (en)
NO (1) NO20032453L (en)
NZ (1) NZ526085A (en)
PL (1) PL365739A1 (en)
RU (1) RU2294934C2 (en)
SK (1) SK7142003A3 (en)
TW (1) TWI243819B (en)
UA (1) UA74593C2 (en)
WO (1) WO2002046194A2 (en)
ZA (1) ZA200305238B (en)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5741908A (en) 1996-06-21 1998-04-21 Minnesota Mining And Manufacturing Company Process for reparing imidazoquinolinamines
UA67760C2 (en) 1997-12-11 2004-07-15 Міннесота Майнінг Енд Мануфакчурінг Компані Imidazonaphthyridines and use thereof to induce the biosynthesis of cytokines
US6756382B2 (en) 1999-06-10 2004-06-29 3M Innovative Properties Company Amide substituted imidazoquinolines
US6541485B1 (en) 1999-06-10 2003-04-01 3M Innovative Properties Company Urea substituted imidazoquinolines
US6331539B1 (en) 1999-06-10 2001-12-18 3M Innovative Properties Company Sulfonamide and sulfamide substituted imidazoquinolines
US6660735B2 (en) 2000-12-08 2003-12-09 3M Innovative Properties Company Urea substituted imidazoquinoline ethers
US6545016B1 (en) 2000-12-08 2003-04-08 3M Innovative Properties Company Amide substituted imidazopyridines
US6545017B1 (en) 2000-12-08 2003-04-08 3M Innovative Properties Company Urea substituted imidazopyridines
UA74852C2 (en) 2000-12-08 2006-02-15 3M Innovative Properties Co Urea-substituted imidazoquinoline ethers
US6664264B2 (en) 2000-12-08 2003-12-16 3M Innovative Properties Company Thioether substituted imidazoquinolines
US20020107262A1 (en) * 2000-12-08 2002-08-08 3M Innovative Properties Company Substituted imidazopyridines
US6525064B1 (en) 2000-12-08 2003-02-25 3M Innovative Properties Company Sulfonamido substituted imidazopyridines
US6677348B2 (en) 2000-12-08 2004-01-13 3M Innovative Properties Company Aryl ether substituted imidazoquinolines
US6664265B2 (en) 2000-12-08 2003-12-16 3M Innovative Properties Company Amido ether substituted imidazoquinolines
US6667312B2 (en) 2000-12-08 2003-12-23 3M Innovative Properties Company Thioether substituted imidazoquinolines
US6677347B2 (en) 2000-12-08 2004-01-13 3M Innovative Properties Company Sulfonamido ether substituted imidazoquinolines
ES2312659T3 (en) 2001-11-29 2009-03-01 3M Innovative Properties Company PHARMACEUTICAL FORMULATIONS THAT INCLUDE A MODIFIER OF THE IMMUNE RESPONSE.
CA2365732A1 (en) 2001-12-20 2003-06-20 Ibm Canada Limited-Ibm Canada Limitee Testing measurements
HUE025145T2 (en) 2002-02-22 2016-01-28 Meda Ab Method of reducing and treating uvb-induced immunosuppression
WO2003101949A2 (en) * 2002-05-29 2003-12-11 3M Innovative Properties Company Process for imidazo[4,5-c]pyridin-4-amines
DK1545597T3 (en) 2002-08-15 2011-01-31 3M Innovative Properties Co Immune Stimulating Compositions and Methods for Stimulating an Immune Response
JP2006503068A (en) 2002-09-26 2006-01-26 スリーエム イノベイティブ プロパティズ カンパニー 1H-Imidazo dimer
CA2510375A1 (en) 2002-12-20 2004-07-15 3M Innovative Properties Company Aryl / hetaryl substituted imidazoquinolines
EP2572714A1 (en) 2002-12-30 2013-03-27 3M Innovative Properties Company Immunostimulatory Combinations
JP2006517974A (en) 2003-02-13 2006-08-03 スリーエム イノベイティブ プロパティズ カンパニー Methods and compositions for IRM compounds and Toll-like receptor 8
EP1599726A4 (en) 2003-02-27 2009-07-22 3M Innovative Properties Co Selective modulation of tlr-mediated biological activity
JP2006519866A (en) 2003-03-04 2006-08-31 スリーエム イノベイティブ プロパティズ カンパニー Prophylactic treatment of UV-induced epidermal neoplasia
AU2004220465A1 (en) 2003-03-13 2004-09-23 3M Innovative Properties Company Method of tattoo removal
WO2004080293A2 (en) * 2003-03-13 2004-09-23 3M Innovative Properties Company Methods for diagnosing skin lesions
KR20050109562A (en) 2003-03-13 2005-11-21 쓰리엠 이노베이티브 프로퍼티즈 컴파니 Methods of improving skin quality
US20040192585A1 (en) 2003-03-25 2004-09-30 3M Innovative Properties Company Treatment for basal cell carcinoma
EP1615665A4 (en) 2003-04-10 2010-10-06 3M Innovative Properties Co Delivery of immune response modifier compounds
WO2004110991A2 (en) 2003-06-06 2004-12-23 3M Innovative Properties Company PROCESS FOR IMIDAZO[4,5-c]PYRIDIN-4-AMINES
BRPI0413558A (en) 2003-08-12 2006-10-17 3M Innovative Properties Co hydroxylamine-substituted imidazo-containing compounds
US8961477B2 (en) 2003-08-25 2015-02-24 3M Innovative Properties Company Delivery of immune response modifier compounds
AU2004268625B2 (en) 2003-08-27 2011-03-31 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted imidazoquinolines
AU2004270201A1 (en) 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for CD5+ B cell lymphoma
AR046046A1 (en) 2003-10-03 2005-11-23 3M Innovative Properties Co IMIDAZOQUINOLINAS ALCOXI SUBSTITUTED. PHARMACEUTICAL COMPOSITIONS.
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
CA2545825A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Hydroxylamine substituted imidazo ring compounds
EP1685129A4 (en) 2003-11-14 2008-10-22 3M Innovative Properties Co Oxime substituted imidazo ring compounds
CA2547020C (en) 2003-11-25 2014-03-25 3M Innovative Properties Company 1h-imidazo[4,5-c]pyridine-4-amine derivatives as immune response modifier
US8940755B2 (en) 2003-12-02 2015-01-27 3M Innovative Properties Company Therapeutic combinations and methods including IRM compounds
JP2007517035A (en) 2003-12-29 2007-06-28 スリーエム イノベイティブ プロパティズ カンパニー Arylalkenyl and arylalkynyl substituted imidazoquinolines
JP2007530450A (en) 2003-12-29 2007-11-01 スリーエム イノベイティブ プロパティズ カンパニー Piperazine, [1,4] diazepan, [1,4] diazocan, and [1,5] diazocan condensed imidazo ring compounds
EP1699788A2 (en) 2003-12-30 2006-09-13 3M Innovative Properties Company Imidazoquinolinyl, imidazopyridinyl and imidazonaphthyridinyl sulfonamides
WO2005094531A2 (en) 2004-03-24 2005-10-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
US8017779B2 (en) 2004-06-15 2011-09-13 3M Innovative Properties Company Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
WO2006065280A2 (en) 2004-06-18 2006-06-22 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
US8026366B2 (en) 2004-06-18 2011-09-27 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
WO2006038923A2 (en) 2004-06-18 2006-04-13 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
EP1831221B1 (en) 2004-12-30 2012-08-08 3M Innovative Properties Company Substituted chiral fused 1,2 imidazo 4,5-c ring compounds
JP5543068B2 (en) 2004-12-30 2014-07-09 スリーエム イノベイティブ プロパティズ カンパニー Chiral fused [1,2] imidazo [4,5-c] cyclic compound
AU2006210392A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune response modifiers
AU2006213746A1 (en) 2005-02-11 2006-08-17 Coley Pharmaceutical Group, Inc. Oxime and hydroxylamine substituted imidazo(4,5-c) ring compounds and methods
AU2006232375A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
EP1869043A2 (en) 2005-04-01 2007-12-26 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines and analogs thereof
AU2006292119A1 (en) * 2005-09-23 2007-03-29 3M Innovative Properties Company Method for 1H-imidazo[4,5-c]pyridines and analogs thereof
CN100344325C (en) * 2005-10-17 2007-10-24 华南师范大学 Medicine for treating cervical cancer and preparation method and application thereof
US7906506B2 (en) 2006-07-12 2011-03-15 3M Innovative Properties Company Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
WO2009034411A1 (en) * 2007-09-12 2009-03-19 Centre National De La Recherche Scientifique Perharidines as cdk inhibitors
CN112587671A (en) 2012-07-18 2021-04-02 博笛生物科技有限公司 Targeted immunotherapy for cancer
BR112016012243A2 (en) * 2013-12-09 2017-08-08 Ucb Biopharma Sprl IMIDAZOPIRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY
DK3092256T3 (en) 2014-01-10 2022-06-20 Birdie Biopharmaceuticals Inc COMPOUNDS AND COMPOSITIONS FOR IMMUNTERAPHY
CN121243402A (en) 2014-07-09 2026-01-02 博笛生物科技有限公司 Anti-PD-L1 combinations for the treatment of tumors
CN105233291A (en) 2014-07-09 2016-01-13 博笛生物科技有限公司 Combination Therapy Compositions and Methods of Combination Therapy for the Treatment of Cancer
CN112587672A (en) 2014-09-01 2021-04-02 博笛生物科技有限公司 anti-PD-L1 conjugates for the treatment of tumors
CN106943597A (en) 2016-01-07 2017-07-14 博笛生物科技(北京)有限公司 Anti-EGFR Combinations for the Treatment of Tumors
CN106943596A (en) 2016-01-07 2017-07-14 博笛生物科技(北京)有限公司 Anti-CD20 Combinations for Treating Tumors
CN115350279A (en) 2016-01-07 2022-11-18 博笛生物科技有限公司 anti-HER 2 combinations for the treatment of tumors
CN108794467A (en) 2017-04-27 2018-11-13 博笛生物科技有限公司 2-amino-quinoline derivatives
CA3067268A1 (en) 2017-06-23 2018-12-27 Birdie Biopharmaceuticals, Inc. Crystalline resiquimod monosulfate anhydrate and its preparation and uses

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL73534A (en) * 1983-11-18 1990-12-23 Riker Laboratories Inc 1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
US4929624A (en) * 1989-03-23 1990-05-29 Minnesota Mining And Manufacturing Company Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
US4988815A (en) * 1989-10-26 1991-01-29 Riker Laboratories, Inc. 3-Amino or 3-nitro quinoline compounds which are intermediates in preparing 1H-imidazo[4,5-c]quinolines
US5389640A (en) * 1991-03-01 1995-02-14 Minnesota Mining And Manufacturing Company 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
DE69229114T2 (en) * 1991-03-01 1999-11-04 Minnesota Mining And Mfg. Co., Saint Paul 1,2-SUBSTITUTED 1H-IMIDAZO [4,5-C] CHINOLIN-4-AMINE
US5268376A (en) * 1991-09-04 1993-12-07 Minnesota Mining And Manufacturing Company 1-substituted 1H-imidazo[4,5-c]quinolin-4-amines
JPH09500128A (en) * 1993-07-15 1997-01-07 ミネソタ マイニング アンド マニュファクチャリング カンパニー Imidazo [4,5-c] pyridin-4-amine
US6069149A (en) * 1997-01-09 2000-05-30 Terumo Kabushiki Kaisha Amide derivatives and intermediates for the synthesis thereof
UA67760C2 (en) * 1997-12-11 2004-07-15 Міннесота Майнінг Енд Мануфакчурінг Компані Imidazonaphthyridines and use thereof to induce the biosynthesis of cytokines
US6331539B1 (en) * 1999-06-10 2001-12-18 3M Innovative Properties Company Sulfonamide and sulfamide substituted imidazoquinolines
US6451810B1 (en) * 1999-06-10 2002-09-17 3M Innovative Properties Company Amide substituted imidazoquinolines
US6541485B1 (en) * 1999-06-10 2003-04-01 3M Innovative Properties Company Urea substituted imidazoquinolines

Also Published As

Publication number Publication date
CN1478090A (en) 2004-02-25
SK7142003A3 (en) 2003-10-07
MXPA03005013A (en) 2003-09-05
AR035670A1 (en) 2004-06-23
JP2004525868A (en) 2004-08-26
RU2294934C2 (en) 2007-03-10
WO2002046194A3 (en) 2003-02-06
WO2002046194A2 (en) 2002-06-13
EE200300273A (en) 2004-02-16
CZ20031593A3 (en) 2004-01-14
RU2003116648A (en) 2005-02-10
TWI243819B (en) 2005-11-21
NO20032453L (en) 2003-07-16
CN1249062C (en) 2006-04-05
HRP20030465A2 (en) 2004-06-30
ZA200305238B (en) 2004-08-27
AU2002239547B2 (en) 2006-11-30
HUP0600592A2 (en) 2006-11-28
NO20032453D0 (en) 2003-05-28
IL155885A0 (en) 2003-12-23
BR0116034A (en) 2004-08-03
UA74593C2 (en) 2006-01-16
EP1343783A2 (en) 2003-09-17
NZ526085A (en) 2004-12-24
CA2431040A1 (en) 2002-06-13
KR20030070048A (en) 2003-08-27
HK1063466A1 (en) 2004-12-31
AU3954702A (en) 2002-06-18

Similar Documents

Publication Publication Date Title
IL155885A0 (en) Substituted imidazopyridines
EG24669A (en) Antivral azaindole derivatives
DE50112082D1 (en) Bulk-acoustic-wave-filter
DE60140430D1 (en) Modulares ofensystem
DZ3293A1 (en) Substituted arylpyrazines
DE60128102D1 (en) Imidazolderivate
AU6227101A (en) Substituted iminoazines
DE50110569D1 (en) Substituierte c-cyclohexylmethylamin-derivate
TWI315197B (en) Combinations
DE50110354D1 (en) Achsantriebsblock mit differentialsperre
DE50112014D1 (en) Stiftheizer
AU5825501A (en) Substituted benzoylcyclohexenones
AU6619001A (en) Liquid-pourers
PL358119A1 (en) Substituted phenyluracils
DE50114303D1 (en) Nsaugluftkanal
DE50008447D1 (en) Aminomethyl-phenyl-cyclohexanonderivate
AU9187601A (en) Triazolo-epothilones
AU2360402A (en) Substituted phenyluracils
GB0117601D0 (en) Pipe-chamfering means
GB0001135D0 (en) Satview
DE60135789D1 (en) Keratomieeinrichtung
AU2117P (en) Gauka Gaura lindheimeri
AU1702P (en) Trailblazer Xanthostemon chrysanthus
GB0022997D0 (en) Disclosure
GB0003844D0 (en) Wooly-warm

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)